Carbazochrome Impurity 9, identified by its CAS number 856783-37-4, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of drug formulation and quality control. As an impurity, it may arise during the synthesis of carbazochrome, a compound known for its hemostatic properties. The characteristics of Carbazochrome Impurity 9 include its molecular structure, which is likely to contain a fused ring system typical of carbazole derivatives, and it may exhibit specific functional groups that influence its chemical reactivity and stability. The compound's solubility, melting point, and spectral properties (such as UV-Vis and NMR) would be essential for its identification and characterization. Additionally, understanding its toxicity and potential biological activity is crucial, especially in the context of pharmaceutical applications, where impurities can affect the safety and efficacy of the final product. Analytical techniques such as HPLC and mass spectrometry are commonly employed to detect and quantify such impurities in drug formulations.

Carbazochrome Impurity 9

856783-37-4: Carbazochrome Impurity 9, identified by its CAS number 856783-37-4, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of drug formulation and quality control. As an impurity, it may arise during the synthesis of carbazochrome, a compound known for its hemostatic properties. The characteristics of Carbazochrome Impurity 9 include its molecular structure, which is likely to contain a fused ring system typical of carbazole derivatives, and it may exhibit specific functional groups that influence its chemical reactivity and stability. The compound's solubility, melting point, and spectral properties (such as UV-Vis and NMR) would be essential for its identification and characterization. Additionally, understanding its toxicity and potential biological activity is crucial, especially in the context of pharmaceutical applications, where impurities can affect the safety and efficacy of the final product. Analytical techniques such as HPLC and mass spectrometry are commonly employed to detect and quantify such impurities in drug formulations.

CAS 856783-37-4

Carbazochrome Impurity 9

Carbazochrome Impurity 15 Sodium Salt

Ref: 4Z-C-163018